Sara E. Lubitz, MD, FACE

Sara Lubitz, MD is an Associate Professor at Rutgers Robert Wood Johnson Medical School where she serves as Program Director for the Endocrinology Diabetes and Metabolism Fellowship. She earned her medical degree from Rutgers New Jersey Medical School (formerly UMDNJ) and completed Internal Medicine residency, chief residency, and Endocrinology fellowship at New York University.  

Areas of clinical interest include pituitary, thyroid and adrenal disease. She serves as Medical Director of the Pituitary Center at Robert Wood Johnson University Hospital and serves as the adult endocrinologist for Comprehensive Care Center for Congenital Adrenal Hyperplasia. Dr. Lubitz leads clinical trials for Acromegaly, Cushing syndrome and hypoparathyroidism.  

Dr. Lubitz is a leader in the field of medical education.  On a local level, she is on the RBHS GME and serves on the RBHS Resident, Faculty, & Coordinator Development Subcommittee.  Dr. Lubitz is the medical endocrinologist for the Sidney Kimmel Medical College of Thomas Jefferson University and IVIRMA Reproductive Endocrinology and Infertility Fellowship. She is an active member of the Association for Program Directors in Endocrinology and Metabolism (APDEM) serving as vice-chair of the American Association of Clinical Endocrinologists (AACE)/APDEM joint liaison committee and the finance committee.  She is the co-author of the  Hypothalamic-Pituitary section of the APDEM fellowship curriculum.  Dr. Lubitz also serves on the AACE Fellows Education Subcommittee and is question writer for ACE Self-Assessment Program (ASAP). 

Publications: 

 
Teresa Brown and Sara Lubitz. Lymphocytic Hypophysitis in the Elderly: A case presentation and review of the literature. Interdisciplinary Neurosurgery: Advanced Techniques and Case Management. 2017 June Vol 8. 43-49  

Anupa Sharma, Eric K. Richfield and Sara E.Lubitz. Acromegaly occurring in a patient with a Pituitary Adenoma, Lymphocytic Hypophysitis, and a Rathke’s Cleft Cyst. AACE Clinical Case Reports. Vol 3 No. 2 Spring 2017 

Ramy Sedhom, MD; Sophia Hu, MD; Anupam Ohri, MD; Dorian Infantino, MD; Sara Lubitz, MD. Symptomatic Cushing’s Syndrome and Hyperandrogenemia in a Steroid Cell Ovarian Neoplasm: A Unique Therapeutic Challenge. J Med Case Rep. 2016 Oct 12;10(1):278 

Pettit AP, Kipen H, Laumbach R, Ohman-Strickland P, Kelly-McNeill K, Cepeda C, Fan ZH, Amorosa L, Lubitz S, Schneider S, Gow A. Disrupted Nitric Oxide Metabolism from Type II Diabetes and Acute Exposure to Particulate Air Pollution.PLoS One. 2015 Dec 14;10(12) 

Sophia Hu, Seena C. Aisner, and Sara E. Lubitz. Cinacalcet for Management of Tertiary Hyperparathyroidism Associated with Chronic Treatment of Hypophosphatemia in an Adult with Tumor-Induced Osteomalacia. AACE Clinical Case Reports: Autumn 2015, Vol. 1, No. 4, pp. e225-e229 

Zhang Z, Amorosa LF, Coyle SM, Macor MA, Lubitz SE, Carson JL, Birnbaum MJ, Lee LY, Haimovich B. Proteolytic Cleavage of AMPKα and Intracellular MMP9 Expression Are Both Required for TLR4-Mediated mTORC1 Activation and HIF-1α Expression in Leukocytes. J Immunol. 2015 Jul 31 

Singh B, Smith JA, Axelrod DM, Ameri P, Levitt H, Danoff A, Lesser M, de Angelis C, Illa-Bochaca I, Lubitz S, Huberman D, Darvishian F, Kleinberg DL. Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial. Breast Cancer Res. 2014 Nov 11;16(6):463 

Hu S, Lubitz SE. Tumor-Induced Osteomalacia Caused by a FGF-23 Producing Mesenchymal Tumor. Journal of General Internal Medicine. 2014 Apr; 29(1): S460 

Axelrod, D; Smith, JA; Singh, B; Ruan, W; Lubitz, S; Kleinberg, DL.  Breast Cancer Chemoprevention in Pre-Neoplastic Lesions with a Somatostatin Analog in Nine Women: A Proof of Principle Trial. Cancer Research 2009 DEC 15 ;69(24):552S-552S 

Chaudhry S,  Lubitz S,  Danoff AAdenomatoid Tumor of the Adrenal Gland: Case Report of a Rare Adrenal Lesion. The Endocrinologist. 2009. 19(5):233-236.